![Darrell Carney](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Darrell Carney
Chief Executive Officer at Chrysalis BioTherapeutics, Inc.
Profile
Darrell H.
Carney is the founder of Chrysalis BioTherapeutics, Inc. and held the titles of Chairman, President & Chief Executive Officer.
Darrell Carney active positions
Companies | Position | Start |
---|---|---|
Chrysalis BioTherapeutics, Inc.
![]() Chrysalis BioTherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Part of Capstone Therapeutics Corp., Chrysalis BioTherapeutics, Inc. develops therapeutics to accelerate the healing of hard and soft tissue. The company is based in Galveston, TX. The company was founded by Dennis L. McWilliams. Chrysalis BioTherapeutics was acquired by Capstone Therapeutics Corp. on August 06, 2004 for $34.50 million. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Chrysalis BioTherapeutics, Inc.
![]() Chrysalis BioTherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Part of Capstone Therapeutics Corp., Chrysalis BioTherapeutics, Inc. develops therapeutics to accelerate the healing of hard and soft tissue. The company is based in Galveston, TX. The company was founded by Dennis L. McWilliams. Chrysalis BioTherapeutics was acquired by Capstone Therapeutics Corp. on August 06, 2004 for $34.50 million. | Health Technology |
- Stock Market
- Insiders
- Darrell Carney